Ellagic acid inhibits PKC signaling by improving antioxidant defense system in murine T cell lymphoma

Molecular Biology Reports

Volumn 41, Issue 7, 2014, Pages 4187-4197

  Mishra, Sudha ^a   Vinayak, Manjula ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Antioxidant enzymes; Ellagic acid; Lymphoma; NF B; PKC; ROS

Indexed keywords

CATALASE; ELLAGIC ACID; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; PROTEIN KINASE C; SUPEROXIDE DISMUTASE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DALTON LYMPHOMA; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; UPREGULATION; AKR MOUSE; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LYMPHOMA, T-CELL; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

MURINAE; MUS;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CATALASE; ELLAGIC ACID; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; ISOENZYMES; LYMPHOMA, T-CELL; MALE; MICE; MICE, INBRED AKR; NF-KAPPA B; OXIDATIVE STRESS; PROTEIN KINASE C; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 84903381276     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3289-0     Document Type: Article

References (42)

1. Alfadda AA, Sallam RM (2012) Reactive oxygen species in health and disease. J Biomed Biotechnol. doi:10.1155/2012/936486
2. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E (2004) Oxidative stress and cell signalling. Curr Med Chem 11:1163-1182 (Pubitemid 38585060)
3. Yu BP (1994) Cellular defenses against damage from reactive oxygen species. Physiol Rev 74:139-162
4. Wu WS (2006) The signaling mechanism of ROS in tumor progression cancer. Metastasis Rev 25:695-705
5. Koivunen J, Aaltonen V, Peltonen J (2006) Protein kinase C (PKC) family in cancer progression. Cancer Lett 235:1-10
6. Saijo K, Mecklenbräuker I, Santana A, Leitger M (2002) Protein kinase Cβ controls nuclear factor κB activation in B cells through selective regulation of the IκB kinase α. J Exp Med 195:1647-1652 (Pubitemid 34666078)
7. Vertegaal AC, Kuiperij HB, Yamaoka S, Courtois G (2000) Protein kinase C-alpha is an upstream activator of the I kappa B kinase complex in the TPA signal transduction pathway to NFkappa B in U2OS cells. Cell Signal 12:759-768 (Pubitemid 32056344)
8. Jost PJ, Ruland J (2007) Aberrant NF-kB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 109:2700-2707 (Pubitemid 46482061)
9. Gloire G, Legrand-Poels S, Piette J (2006) NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72(11):1493-1505 (Pubitemid 44666727)
10. Kim SO, Chun KS, Kundu JK, Surh YJ (2004) Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-kB and p38 MAPK in mouse skin. BioFactors 21:27-31 (Pubitemid 40921822)
11. Takada Y, Murakami A, Aggarwal BB (2005) Zerumbone abolishes NF-kappa B and Ik Bα kinase activation leading to suppression of antiapoptotic and metastatic gene expression, up regulation of apoptosis, and down regulation of invasion. Oncogene 24(46):6957-6969 (Pubitemid 41509418)
12. Fjaeraa C, Nanberg E (2009) Effect of ellagic acid on proliferation, cell adhesion and apoptosis in SH-SY5Y human neuroblastoma cells. Biomed Pharmacother 63:254-261
13. Mishra S, VinayakM(2011) Anti-carcinogenic action of ellagic acid mediated viamodulation of oxidative stress regulated genes inDalton lymphoma bearing mice. Leukemia Lymphoma 52(11):2155-2161
14. Woodbury W, Spencer AK, Stahman MA (1971) An improved procedure using ferricyanide for detecting catalase isozymes. Anal Biochem 44:301-305
15. Pathak C, Jaiswal YK, Vinayak M (2008) Queuine promotes antioxidant defence system by activating cellular antioxidant enzyme activities in cancer. Biosci Rep 28:73-81
16. Beauchamp C, Fridovich I (1971) Superoxide dismutase: improved assay and assay applicable to acrylamide gel. Anal Biochem 44:276-286
17. Verma N, Vinayak M (2009) Semecarpus anacardium nut extract promotes the antioxidant defence system and inhibits anaerobic metabolism during development of lymphoma.BiosciRep 29:151-164
18. Lin CH, Chen H, Hou W (2002) Activity staining of glutathione peroxidase after electrophoresis on native and sodium dodecyl sulphate polyacrylamide gels. Electrophoresis 23:513-516 (Pubitemid 34232948)
19. Hou WC, Liang HJ, Wang CC, Liu DJ (2004) Detection of glutathione reductase after electrophoresis on native or sodium dodecyl sulphate polyacrylamide gels. Electrophoresis 25:2926-2931
20. Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acids Res 11:1475-1489
21. Mishra S, Vinayak M (2013) Ellagic acid checks lymphoma promotion via regulation of PKC signaling pathway. Mol Biol Rep 40:1417-1428
22. Liu SF, Ye X, Malik AB (1999) Inhibition of NF-kB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation 100:1330-1337 (Pubitemid 29440127)
23. Goh J, Enns L, Fatemie S, Hopkins H, Morton J, Brewer CP, Ladiges W (2011) Mitochondrial targeted catalase suppresses invasive breast cancer in mice. BMC Cancer 11:191
24. Glorieux C, Dejeans N, Sid B, Beck R, Calderon PB, Verrax J (2011) Catalase over-expression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochem Pharmacol 82:1384-1390
25. Clair DS, Zhao Y, Chaiswing L, Oberley T (2005) Modulation of skin tumorigenesis by SOD. Biomed Pharmacother 59:209-214 (Pubitemid 40603335)
26. Monari M, Trinchero A, Calabrese C, Cattani O, Serrazanetti GP, Foschi J (2006) Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? Biomarkers 11(6):574-584 (Pubitemid 44614828)
27. Ough M, Lewis A, Zhang Y, Hinkhouse MM, Ritchie JM (2004) Inhibition of cell growth by over expression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Rad Res 38:1223-1233 (Pubitemid 39654512)
28. Venkataraman S, Jiang X,Weydert C, Zhang Y (2005) Manganese superoxide dismutase over expression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 24(1):77-89 (Pubitemid 40143867)
29. Hu Y, Rosen DG, Zhou Y, Feng L, Yang G, Liu J, Huang P (2005) Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. Biol Chem 280(47):39485-39492 (Pubitemid 41713906)
30. Sharma R, Vinayak M (2013) α-Tocopherol prevents lymphoma by improving antioxidant defense system of mice. Mol Biol Rep 40:839-849
31. Das L, Vinayak M (2012) Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-jB signalling in lymphoma-bearing mice. Biosci Rep 32:161-170
32. Verma N, Vinayak M (2009) Effect of Terminalia arjuna on antioxidant defense system in cancer. Mol Biol Rep 36:159-164
33. Verma N, Vinayak M (2008) Antioxidant action of Andrographis paniculata on lymphoma. Mol Biol Rep 35:535-540
34. Brigelius-Flohé R (1999) Tissue-specific functions of individual glutathione peroxidases. Free Radical Biol Med 27:951-965
35. Liu J, Hinkhouse MM, Sun W, Weydert CJ, Ritchie JM, Oberley LW, Cullen JJ (2004) Redox regulation of pancreatic cancer cell growth: role of glutathione peroxidase in the suppression of the malignant phenotype. Hum Gene Ther 15(3):239-250 (Pubitemid 38365913)
36. Tetlow N, Coggan M, Casarotto MG, Board PG (2004) Functional polymorphism of human glutathione transferase A3: effects on xenobiotic metabolism and steroid biosynthesis. Pharmacogenetics 14(10):657-663 (Pubitemid 39411265)
37. Kuzniak VK, Szaefer H, Dubowska WB (2008) Hepatic and extrahepatic expression of glutathione S-transferase isozymes in mice and its modulation by naturally occurring phenolic acids. Environ Toxicol Pharmacol 25:27-32 (Pubitemid 350198998)
38. Granado-Serrano AB, Martín MA, Bravo L, Goya L, Ramos S (2012) Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: involvement of p38. Chem Biol Interact 195(2):154-164
39. Besson A, Yong VW (2000) Involvement of p21Waf1/Cip1 in protein kinase C alpha-induced cell cycle progression. Mol Cell Biol 20:4580-4590 (Pubitemid 30396106)
40. Kamimura K, Hojoand H, Abe M (2004) Characterization of expression of protein kinase C isozymes in human B-cell lymphoma: relationship between its expression and prognosis. Pathol Int 54:224-230 (Pubitemid 38669976)
41. Dorota G et al (2010) Protein kinase C gama in colon cancer cells: expression, Thr514 phosphorylation and sensitivity to butyrate-mediated up regulation as related to the degree of differentiation. Chemi Biol Interact 185:25-32
42. Chung CH, Parker JS, Ely KJ, Yajun Yi Y et al (2006) Gene expression profiles identify epithelial-to-mesenchymal carcinoma characteristics of a high-risk head and neck squamous cell transition and activation of nuclear factor- kB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res 66:8210-8218 (Pubitemid 44299189)